Hemopore
Splint, Intranasal Septal. 510(k) K141816, from Polyganics B.V., (Groningen, NL). Product code LYA, class 1.
As of Nov 20, 2026, K141816 is an FDA 510(k) held by Polyganics B.V.,, substantially equivalent on Oct 23, 2014 after 108 days, with no recalls tied to it in FDA's recall database.
- Review time: 108 days
- Recalls: 0
HEMOPORE® is intended for use in patients undergoing nasal/sinus surgery as a temporary wound dressing. HEMOPORE® functions as a topical hemostatic aid to control mild bleeding by tamponade effect, blood absorption, platelet activation and aggregation. It acts as an adjunct to aid in the natural healing process as a space occupying stent to separate and support tissues.
- Nasopore Nasal Dressing, Model Ndox-Yyy/ZzK052099 · Polyganics B.V., · Nov 21, 2005
- Posisep and Posisep X Hemostat Dressing/Intranasal SplintK122494 · Hemostasis, LLC · Mar 27, 2013
- TurbAlignK243655 · Spirair, Inc. · Jul 11, 2025
- Epi-Stop Nasal Gel/epistaxis packK230142 · Biomed Ent, Inc. · Mar 22, 2023
- SPIWay Endonasal Access GuideK213153 · Spiway, LLC · Oct 27, 2021
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Jul 7, 2014
- Review panel
- Ear, Nose, Throat
- Regulation
- 21 CFR 874.4780
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files